Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients.
about
MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNAComprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancerRole of inherited defects of MYH in the development of sporadic colorectal cancerGermline susceptibility to colorectal cancer due to base-excision repair gene defects.Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer riskGastrointestinal tract cancers: Genetics, heritability and germ line mutationsGenetic testing for hereditary colorectal cancer.The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance.MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal CancerMUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.MUTYH Associated Polyposis (MAP).The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysisIncreased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.Simple and complex genetics of colorectal cancer susceptibility.Molecular basis and diagnostics of hereditary colorectal cancers.Serrated pathway colorectal cancer in the population: genetic considerationACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromesRecently identified colon cancer predispositions: MYH and MSH6 mutations.The genetics of FAP and FAP-like syndromes.The role of MYH and microsatellite instability in the development of sporadic colorectal cancer.Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up.Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testingGermline MutY human homologue mutations and colorectal cancer: a multisite case-control study.Pathological features of colorectal carcinomas in MYH-associated polyposis.Prevalence of MYH-associated polyposis related to three recurrent mutations in Morocco.Frequent mutation in North African patients with MUTYH-associated polyposis.Association of MUTYH and colorectal cancer.Colorectal cancer risk in monoallelic carriers of MYH variants.ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease.Association between genetic polymorphisms of the base excision repair gene MUTYH and increased colorectal cancer risk in a Japanese population.Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer.MYH mutations are rare in prostate cancer.Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.Implication of MYH in colorectal polyposis.
P2860
Q21131242-F26B3026-1514-44E2-9273-20A56403D2C2Q28247491-BE7D56BB-054E-4D29-9E96-EA250C691DFFQ28251876-17C028A1-67A4-4C84-A8F5-2A0549F99C54Q28254275-44860A55-3A89-4294-A9AB-E14842510FBAQ28291433-F1B9F4BE-5651-4FFA-BD89-E11E608818CBQ33599436-BD438AA1-06C8-4F04-AEDA-6E2E10820525Q33649978-A94223FD-8483-4D9E-A530-E2C313ACB0B2Q33721594-06FA834B-D90C-4A6E-9209-AAD82304C30DQ33722509-5DCD5E2F-4B29-40F6-94A4-771E20EEB14AQ33765170-583C32E8-705A-4F3D-8803-15C04178C083Q34433744-7D4E84AD-6C3C-4648-B1C9-CC5C5BECE5CFQ34608633-4186F471-89DC-49AB-B1CE-86A9B2BDE701Q34669614-4F38D565-2E56-4595-AE04-0A7BACC7C016Q35587031-E4409DD3-314E-4D50-975E-E04334AA56D1Q35589985-DD87D412-02E4-46D8-B181-AFE2EBC5896FQ35841132-2B88FEDF-FD6C-4E46-BAC7-72663516D18EQ35915251-AD3061F8-BE63-4FA6-A09C-73D5743AF89AQ36023417-CA1A0A4B-D787-4945-BB49-059990E4F0F3Q36416282-C535C3BF-039B-4C90-90FD-510DE9B67ED9Q36484887-529ED3FB-CE5A-48AD-AB7A-84ECE45C18A8Q36602699-41C58AA4-9C91-445C-B8C6-96165F662D68Q36611848-FD6A9986-C8F8-43B0-98D3-4EB106F1837EQ36769783-ABFB66BC-875C-48EC-861B-85DD685FA8A0Q36997258-67A3DE6B-5F2B-4A9A-A616-77B218A80BC4Q37337396-D52AA09F-229C-44E4-8EE0-132EE6FE55FAQ37368316-5A74EEDB-1082-4E10-87C9-0B9A7A5AE7E5Q39155241-3D6587F6-EBD9-4700-9847-98E8FD55D99CQ39168021-A8D9D85F-93F9-491E-A707-C362177997A5Q42277991-7998D7D1-7AA8-401F-AA6A-17DDC3ADD2ADQ43248924-36F17D9C-26EE-4DD0-A359-916F3C089DFAQ43893519-90B9EB2D-509C-4CE7-BD57-6462EA3456F5Q44785975-DFEDAE13-EAAD-4B57-B536-9577AFCA6331Q44961780-59A564FA-63D7-4360-B29B-17115844CFB4Q46756191-E1B8F910-CC22-4EE0-AEEA-F4E97E37251DQ51925345-B21512F1-5A35-4794-B3BD-D969697ACB6FQ53321594-3C0129B1-93FD-47F2-9EB2-8EDE7AD48857Q53338016-24976E02-20B4-40D6-9756-B15B20262454Q53751565-F8571360-97AC-46C0-BDD7-0DEF7D1EC8E5Q54382898-CE3385BB-1365-4FED-BBE7-B867D9B0D2D7Q54451550-2B56E5EC-9012-4F1D-A746-3FA04EDED7DA
P2860
Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@ast
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@en
type
label
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@ast
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@en
prefLabel
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@ast
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@en
P2093
P2860
P50
P1476
Proportion and phenotype of MY ...... sh colorectal cancer patients.
@en
P2093
Anu Suomalainen
Auli Karhu
Heikki J Järvinen
Lara Lipton
Matti Eskelinen
Susa Enholm
Tuija Hienonen
Vesa Kärjä
P2860
P304
P356
10.1016/S0002-9440(10)63443-8
P407
P577
2003-09-01T00:00:00Z